首页> 外文学位 >Targeting annexin II function with small molecule natural products as a novel anticancer strategy.
【24h】

Targeting annexin II function with small molecule natural products as a novel anticancer strategy.

机译:针对小分子天然产物的膜联蛋白Ⅱ功能是一种新型的抗癌策略。

获取原文
获取原文并翻译 | 示例

摘要

The establishment and dissemination of cancers is dependent not only on the dysregulation of cell autonomous processes, but also on the ability of tumor cells to establish an adequate blood supply in their host environment (neoangiogenesis) and escape local tissue constraints (metastasis). The key proteins that mediate each of these processes are highly sought after as potential therapeutic targets. Annexin AII (AII) is a cellular protein that plays a critical role in multiple cancer relevant processes such as metastasis, angiogenesis, and mitogenic signal transduction. Studies have correlated elevated levels of AII with aggressive tumors. However, the multiple roles of AII have made it difficult to define specific mechanisms by which the protein can contribute to a malignant phenotype. Using a cell-based reporter assay, we have identified Withaferin A (WA) from Withania somnifera, a plant with medicinal uses that date back to over 3,000 years in Ayurvedic medicine, as a small molecule natural product that interacts with the AII protein. Work in our laboratory has shown that WA disrupts F-actin organization via a covalent interaction with AII that results in concentration-dependent cytotoxicity and marked anti-invasive activity in tumor cells. We also determined the effects of WA on AII-dependent endothelial cell plasmin generation and network formation. In vivo mouse xenograft models utilizing WA against Ewing's sarcoma were performed to further characterize the anti-tumor activity of WA. Our findings indicate that WA is a potent anti-tumor agent, resulting in decreased endothelial cell plasmin generation, tumor growth inhibition and reduced blood vessel formation both in vitro and in vivo. 15 The potent anti-tumor activity of WA suggests that AII represents a previously unexploited target for therapeutic intervention by small molecule drugs. Our in vitro findings and animal studies indicate that WA therapy has potent anti-tumor effects and supports the notion of WA serving as lead for the synthesis of new compounds that target AII function. Furthermore, as a small molecule modulator of AII function, WA provides a tool to study the complex cellular functions of AII.
机译:癌症的建立和传播不仅取决于细胞自主过程的失调,还取决于肿瘤细胞在其宿主环境中建立足够的血液供应(新血管生成)并逃脱局部组织限制(转移)的能力。介导这些过程中的每一个的关键蛋白都被高度寻求作为潜在的治疗靶标。 Annexin AII(AII)是一种细胞蛋白,在多种癌症相关过程(如转移,血管生成和有丝分裂信号转导)中发挥关键作用。研究已将AII水平升高与侵袭性肿瘤相关联。然而,AII的多种作用使得难以定义蛋白质可以通过其促成恶性表型的特定机制。使用基于细胞的报告基因检测,我们已将来自Withania somnifera的Withaferin A(WA)鉴定为与AII蛋白相互作用的小分子天然产物,该植物在阿育吠陀医学中的药用历史可追溯到3,000多年。我们实验室的研究表明,WA通过与AII的共价相互作用破坏F-肌动蛋白的组织,导致肿瘤细胞中浓度依赖性的细胞毒性和明显的抗侵袭活性。我们还确定了WA对AII依赖性内皮细胞纤溶酶生成和网络形成的影响。进行了利用WA对抗尤因氏肉瘤的体内小鼠异种移植模型,以进一步表征WA的抗肿瘤活性。我们的发现表明,WA是一种有效的抗肿瘤剂,可降低内皮细胞纤溶酶的产生,抑制肿瘤生长,并减少体内外的血管形成。 15 WA的强大抗肿瘤活性表明,AII代表了小分子药物进行治疗干预之前未开发的靶标。我们的体外研究结果和动物研究表明,WA治疗具有强大的抗肿瘤作用,并支持WA的概念,WA可以作为合成靶向AII功能的新化合物的先导。此外,作为AII功能的小分子调节剂,WA提供了研究AII复杂细胞功能的工具。

著录项

  • 作者

    Falsey, Ryan Richard.;

  • 作者单位

    The University of Arizona.;

  • 授予单位 The University of Arizona.;
  • 学科 Health Sciences Oncology.
  • 学位 Ph.D.
  • 年度 2007
  • 页码 182 p.
  • 总页数 182
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号